Sichuan Huiyu Pharmaceutical Hits Day Low Amid Price Pressure at CNY 15.97

Sichuan Huiyu Pharmaceutical Co., Ltd. has experienced a significant decline today, with the stock dropping by 5.49% and reaching an intraday low of CNY 15.97. This performance stands in contrast to the broader market, as the China Shanghai Composite index has only decreased by 1.7% during the same period. Over the past week, Sichuan Huiyu's stock has fallen by 7.28%, and its monthly performance shows a notable decline of 19.9%. Year-to-date, the stock has decreased by 9.05%, while the one-year performance reflects a modest gain of 0.56%, significantly lagging behind the China Shanghai Composite's return of 16.95%. Financial metrics indicate challenges for the company, with net sales declining at an annual rate of 15.85% and operating profit decreasing by 139.44% over the last five years. Recent half-year results show net sales of CNY 502.7 million, down 17.49%, and a net profit of CNY 53.87 million, down 31.32%. The return on capital employed (ROCE) has also reached a low of 1.24%, further highlighting the company's current market position.